[HTML][HTML] … breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy …
D Von Ah, EF Tallman - Journal of pain and symptom management, 2015 - Elsevier
… this study were collected at one time at baseline assessment. … designed to assess cognitive
complaints in cancer patients. … with cancer patients and also validated with cancer patients …
complaints in cancer patients. … with cancer patients and also validated with cancer patients …
Assessing responses to cancer therapy using molecular imaging
AA Neves, KM Brindle - … et Biophysica Acta (BBA)-Reviews on Cancer, 2006 - Elsevier
… Qualitative visualization of PET scans is often sufficient to assess tumor response after therapy…
of methods to assess quantitatively the response to cancer therapy are currently thought to …
of methods to assess quantitatively the response to cancer therapy are currently thought to …
Psychometric analysis of the Functional Assessment of Cancer Therapy‐General (FACT‐G) scale in a rural sample
P Winstead‐Fry, A Schultz - … Journal of the American Cancer …, 1997 - Wiley Online Library
… The authors of the current study chose the FACT-G scale for systematic replication
because it met criteria of reliability, validity, ease of administration, and ability to assess …
because it met criteria of reliability, validity, ease of administration, and ability to assess …
[HTML][HTML] … and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and …
… Assessment of Cancer Therapy (FACT, also known as FACIT: Functional Assessment of
Chronic Illness Therapy),1… to include QOL as a primary endpoint in cancer clinical trials. Several …
Chronic Illness Therapy),1… to include QOL as a primary endpoint in cancer clinical trials. Several …
Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
D Cella, S Yount, H Du, R Dhanda… - The journal of …, 2006 - europepmc.org
The Functional Assessment of Cancer Therapy (FACT)-Kidney Symptom Index (FKSI) was
developed and validated to enhance treatment decision-making, practice guidelines, …
developed and validated to enhance treatment decision-making, practice guidelines, …
Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update
W Dale, HD Klepin, GR Williams… - Journal of Clinical …, 2023 - ascopubs.org
… the prior guideline that geriatric assessment (GA), including … assessments for all patients
over 65 years old with cancer. … with cancer (65+ years old) receiving systemic therapy with …
over 65 years old with cancer. … with cancer (65+ years old) receiving systemic therapy with …
Use of PET for monitoring cancer therapy and for predicting outcome
WA Weber - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
… is an accurate test for differentiating residual viable tumor tissue from therapy-induced
fibrosis. Furthermore, quantitative assessment of therapy-induced changes in tumor 18 F-FDG …
fibrosis. Furthermore, quantitative assessment of therapy-induced changes in tumor 18 F-FDG …
[HTML][HTML] Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients
A Degboe, C Ivanescu, JM Rohay, RR Turner… - … Care in Cancer, 2019 - Springer
… The recent increase in emerging novel therapies in the bladder cancer therapeutic …
Assessment of Cancer Therapy-Bladder (FACT-Bl) in 182 patients with advanced urothelial cancer (…
Assessment of Cancer Therapy-Bladder (FACT-Bl) in 182 patients with advanced urothelial cancer (…
Screening, risk assessment, and the approach to therapy in patients with prostate cancer
SJ Freedland - Cancer, 2011 - Wiley Online Library
… The major challenge in prostate cancer is to identify patients at higher risk of death and to …
, and nomograms available for risk assessment in prostate cancer. For patients with localized …
, and nomograms available for risk assessment in prostate cancer. For patients with localized …
Overcoming implementation challenges of personalized cancer therapy
F Meric-Bernstam, GB Mills - Nature reviews Clinical oncology, 2012 - nature.com
… Indeed, we are already finding that multiple rounds of assessment of individual markers is
not only expensive, but testing may also be limited by the amount of tissue available as it can …
not only expensive, but testing may also be limited by the amount of tissue available as it can …